FR2007399A1 - Organotherapeutic solution for administering large drug - doses - Google Patents

Organotherapeutic solution for administering large drug - doses

Info

Publication number
FR2007399A1
FR2007399A1 FR6910326A FR6910326A FR2007399A1 FR 2007399 A1 FR2007399 A1 FR 2007399A1 FR 6910326 A FR6910326 A FR 6910326A FR 6910326 A FR6910326 A FR 6910326A FR 2007399 A1 FR2007399 A1 FR 2007399A1
Authority
FR
France
Prior art keywords
organotherapeutic
molecular weight
solution
doses
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR6910326A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AEGROTI SALUS SUPREMA LEX ASSL
Original Assignee
AEGROTI SALUS SUPREMA LEX ASSL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AEGROTI SALUS SUPREMA LEX ASSL filed Critical AEGROTI SALUS SUPREMA LEX ASSL
Publication of FR2007399A1 publication Critical patent/FR2007399A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR6910326A 1968-04-05 1969-04-03 Organotherapeutic solution for administering large drug - doses Withdrawn FR2007399A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1767149 1968-04-05

Publications (1)

Publication Number Publication Date
FR2007399A1 true FR2007399A1 (en) 1970-01-09

Family

ID=5699245

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6910326A Withdrawn FR2007399A1 (en) 1968-04-05 1969-04-03 Organotherapeutic solution for administering large drug - doses

Country Status (3)

Country Link
AT (1) AT295035B (fr)
CH (1) CH551376A (fr)
FR (1) FR2007399A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0012774A4 (fr) * 1978-03-31 1981-08-28 Snowden Co Ltd Agent therapeutique vegetatif.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0012774A4 (fr) * 1978-03-31 1981-08-28 Snowden Co Ltd Agent therapeutique vegetatif.

Also Published As

Publication number Publication date
AT295035B (de) 1971-12-27
CH551376A (de) 1974-07-15

Similar Documents

Publication Publication Date Title
US4999375A (en) Psoralen reagent compositions for extracorporeal treatment of blood
JPS62185017A (ja) 変形性関節症および関連した病気の治療のためのｎ−アセチルグルコサミンの使用
RU94022479A (ru) Применение антиэстрогенных соединений, а также фармацевтически приемлемых солей и сольватов для уменьшения концентрации глюкозы в крови, фармацевтический препарат
DK47089A (da) Middel med oedelaeggende virkning paa maligne tumorer, fremgangsmaade til fremstilling af saadanne midler og anvendelse af disse til terapeutisk behandling af cancer
EA000885B1 (ru) Лекарственное средство и способ медикаментозного воздействия на организм
BR9500436A (pt) Produtos uso de um g-csf uso de uma proteína tnf ligante processo para o tratamento e/ou prevenção do choque séptico
Haden HISTORICAL ASPECTS OF IRON THERAPY IN ANEMIA: CHAIRMAN'S ADDRESS
CA2100657A1 (fr) Methode de traitement des arthropathies algiques aigues et chroniques chez l'homme et chez d'autres mammiferes
DE59409394D1 (de) Therapeutisches system zur behandlung der psoriasis
BR0206954A (pt) Processo de terapia para câncer
FR2007399A1 (en) Organotherapeutic solution for administering large drug - doses
WO1981001653A1 (fr) Medicament sedatif
RU2085194C1 (ru) Средство для местного применения
EP1272197B1 (fr) Combinaison de lecithine avec l'acide ascorbique
KR890000108A (ko) 종양 치료용 약제학적 조성물
CA2516458A1 (fr) Utilisation de composes de kahalalide pour la fabrication d'un medicament pour le traitement de psoriasis
RU2019180C1 (ru) Средство для лечения подкожной фибросаркомы и способ его получения
RU94042656A (ru) Способ лечения первичного рака печени и набор для лечения первичного рака печени
WO2024081428A3 (fr) Modulateurs sélectifs de transcription à régulation ahr et méthode d'utilisation de tels modulateurs pour traiter le cancer
RU2200557C1 (ru) Способ лечения гипертрофических и келоидных рубцов
SU917839A1 (ru) Способ лечени псориаза
US4885288A (en) Pharmaceutical compositions containing lysine acetylsalicylate
RU2157218C2 (ru) Способ иммунотерапии хронических воспалительных заболеваний
RU2066192C1 (ru) Радиопротекторное средство
RU94015449A (ru) Способ лечения послеоперационных офтальмохирургических осложнений

Legal Events

Date Code Title Description
ST Notification of lapse